The latest from the Indica Labs blog Overview: The Clinical Trials Module in HALO AP Platforms  The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared...

VISTA, California, June 25, 2025 – In a significant stride toward transforming the future of cancer diagnostics and research, Leica Biosystems proudly showcases its latest digital pathology portfolio solutions at booth #50 during the European...

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6,...

Clario and PathAI: Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders Strategic Partnership: Streamlined, single-vendor solution improves diagnostic...

MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...

Proscia: Pathology at the Speed of Life Streamlining Clinical Development and Maximizing Trial Success with an Enterprise Pathology Platform October 16 11:00 AM — 11:45 AM EDT Register Join us for an exciting discussion about...